Argenica Therapeutics Statistics

Total Valuation

ASX:AGN has a market cap or net worth of AUD 96.98 million. The enterprise value is 81.90 million.

Market Cap	96.98M
Enterprise Value	81.90M

Important Dates

The last earnings date was Monday, May 19, 2025.

Earnings Date	May 19, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:AGN has 128.45 million shares outstanding. The number of shares has increased by 46.14% in one year.

Current Share Class	128.45M
Shares Outstanding	128.45M
Shares Change (YoY)	+46.14%
Shares Change (QoQ)	+16.78%
Owned by Insiders (%)	25.30%
Owned by Institutions (%)	18.34%
Float	91.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.49
PB Ratio	7.35
P/TBV Ratio	7.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.58
EV / Sales	26.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.95

Current Ratio	6.95
Quick Ratio	6.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12,573.18

Financial Efficiency

Return on equity (ROE) is -53.14% and return on invested capital (ROIC) is -35.82%.

Return on Equity (ROE)	-53.14%
Return on Assets (ROA)	-29.50%
Return on Invested Capital (ROIC)	-35.82%
Return on Capital Employed (ROCE)	-42.98%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.14% in the last 52 weeks. The beta is 0.79, so ASX:AGN's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+4.14%
50-Day Moving Average	0.74
200-Day Moving Average	0.73
Relative Strength Index (RSI)	46.54
Average Volume (20 Days)	118,637

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:AGN had revenue of AUD 3.08 million and -5.26 million in losses. Loss per share was -0.04.

Revenue	3.08M
Gross Profit	3.08M
Operating Income	-5.67M
Pretax Income	-5.26M
Net Income	-5.26M
EBITDA	n/a
EBIT	-5.67M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 15.08 million in cash and n/a in debt, giving a net cash position of 15.08 million or 0.12 per share.

Cash & Cash Equivalents	15.08M
Total Debt	n/a
Net Cash	15.08M
Net Cash Per Share	0.12
Equity (Book Value)	13.19M
Book Value Per Share	0.10
Working Capital	13.19M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.10M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -184.14% and -170.72%.

Gross Margin	100.00%
Operating Margin	-184.14%
Pretax Margin	-170.72%
Profit Margin	-170.72%
EBITDA Margin	n/a
EBIT Margin	-184.14%
FCF Margin	n/a

Dividends & Yields

ASX:AGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.14%
Shareholder Yield	n/a
Earnings Yield	-5.42%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:AGN has an Altman Z-Score of 21.01.

Altman Z-Score	21.01
Piotroski F-Score	n/a